Literature DB >> 483159

Progressive essential iris atrophy, Chandler's syndrome, and the iris nevus (Cogan-Reese) syndrome: a spectrum of disease.

M B Shields.   

Abstract

Progressive essential iris atrophy, Chandler's syndrome, and the iris nevus (Cogan-Reese) syndrome are considered to be variations of a single disease process, which is characterized by abnormalities of the cornea, anterior chamber angle, and iris. In each variation, the typical patient is a white woman with unilateral disease, negative family history, and an onset of symptoms in early to middle adulthood. Since the membrane theory of Campbell suggests that the disease is a fundamental abnormality of the corneal endothelium, rather than the iris, the term "iridocorneal endothelial syndrome," as proposed by Yanoff, may be an appropriate inclusive term for the spectrum of disease, although further study of the pathogenesis is needed. For each variation of the disease, corneal edema and secondary glucoma are both treated primarily by medical or surgical reduction of the intraocular pressure, although penetrating keratoplasty is occasionally required for cases with advanced corneal edema.

Entities:  

Mesh:

Year:  1979        PMID: 483159     DOI: 10.1016/0039-6257(79)90143-7

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  25 in total

1.  Ultrasound biomicroscopy of Chinese eyes with iridocorneal endothelial syndrome.

Authors:  M Zhang; J Chen; L Liang; A M Laties; Z Liu
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

2.  A clinicopathologic study of posterior polymorphous dystrophy:implications for pathogenetic mechanism of the associated glaucoma.

Authors:  A B Threlkeld; W R Green; H A Quigley; Z de la Cruz; W J Stark
Journal:  Trans Am Ophthalmol Soc       Date:  1994

3.  Axenfeld-Rieger syndrome: a theory of mechanism and distinctions from the iridocorneal endothelial syndrome.

Authors:  M B Shields
Journal:  Trans Am Ophthalmol Soc       Date:  1983

4.  Posterior polymorphous dystrophy of the cornea (Schlichting). An unusual clinical variant.

Authors:  H Witschel; R Sundmacher; H Theopold; W Jaeger
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1980

5.  The corneal endothelium and Descemet's membrane in the iridocorneal endothelial syndrome.

Authors:  J M Portis; R L Stamper; W H Spencer; R G Webster
Journal:  Trans Am Ophthalmol Soc       Date:  1985

6.  Unusual presentation of presumed posterior polymorphous dystrophy associated with iris heterochromia, band keratopathy, and keratoconus.

Authors:  Helene Y Lam; Janey L Wiggs; Ula V Jurkunas
Journal:  Cornea       Date:  2010-10       Impact factor: 2.651

7.  Endothelial keratoplasty in the management of irido-corneal endothelial syndrome.

Authors:  S Chaurasia; M Ramappa; P Garg; S I Murthy; S Senthil; V S Sangwan
Journal:  Eye (Lond)       Date:  2013-01-25       Impact factor: 3.775

8.  [Diagnostic methods in the clinical evaluation of iridocorneal endothelial syndrome].

Authors:  T Gračner; S Trpin; T Šarenac; D Pahor
Journal:  Ophthalmologe       Date:  2016-12       Impact factor: 1.059

9.  Unique variations and characteristics of iridocorneal endothelial syndrome in China: a case series of 58 patients.

Authors:  Bo Feng; Xin Tang; Hong Chen; Xia Sun; Ningli Wang
Journal:  Int Ophthalmol       Date:  2017-10-10       Impact factor: 2.031

10.  Progression and regression of partial corneal involvement in the iridocorneal endothelial syndrome.

Authors:  W M Bourne; R F Brubaker
Journal:  Trans Am Ophthalmol Soc       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.